Serum IL-10 and IL-17 have been shown to exhibit satisfactory performances in discriminating between patients with active LN and patients with inactive LN and displayed a strong correlation with the disease activity parameters (see Table 2 for the detailed metrics) [61,77]. The gene discussed is IL10; the disease is lobular neoplasia.